METHYL 6-FLUORO-2-METHYL-3-NITROBENZOATE, 95.0%, 1g

1-Iodo-2-methoxynaphthalene, 95+%, 1g

2-([3,3'-Bipyridin]-4-ylthio)-N-(methylsulfonyl)acetamide, 97%, 25mg

N-[(1S,2S)-2-Amino-1,2-diphenylethyl]-2,3,4,5,6-pentafluorobenzenesulfonamide, 97%, 100mg

6-Methylquinolin-4-ol, 95.0%, 10g

2-Chloro-4-methoxy-5-nitropyridine, 95.0%, 5g

5,6-Diaminonicotinic acid, 95.0%, 100mg

7-TFA-ap-7-Deaza-dG, 100mg

DBD-H [=4-(N,N-Dimethylaminosulfonyl)-7-hydrazino-2,1,3-benzoxadiazole] [for HPLC Labeling]>98.0%(HPLC)100mg

3-(2-Bromo-1-hydroxyethyl)-5-chlorothiophene-2-sulfonamide, 97%, 250mg

3,3-Bis(bromomethyl)-1-tosylazetidine, 95.0%, 100mg

Acide chlorogénique, min 97 %, 1 g, emballage en verre

tert-butyl 3'-amino-4',5'-dihydro-2'H-spiro[cyclopentane-1,6'-pyrrolo[3,4-c]pyrazole]-5'-carboxylate, 98%, 100mg